Senti Biosciences is trading 7.58% up at $0.33, with no clearly identified company-specific announcement on September 22, 2026.

  • Recent coverage highlights earlier financing and strategic-transaction developments, including a $2.5 million equity commitment.
  • Those announcements predate the current session.
  • Broader market sentiment is mildly positive, but major indexes are mixed and below the threshold for a strong market-wide explanation.